203 related articles for article (PubMed ID: 27151016)
1. [Clinical Features of 46 Multiple Myeloma Patients with Different Renal Pathology].
Su YT; Xie XS; Sun H; Ma J; Wan DM; Liu YF
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2016 Apr; 24(2):487-91. PubMed ID: 27151016
[TBL] [Abstract][Full Text] [Related]
2. Clinicopathologic correlations in multiple myeloma: a case series of 190 patients with kidney biopsies.
Nasr SH; Valeri AM; Sethi S; Fidler ME; Cornell LD; Gertz MA; Lacy M; Dispenzieri A; Rajkumar SV; Kyle RA; Leung N
Am J Kidney Dis; 2012 Jun; 59(6):786-94. PubMed ID: 22417785
[TBL] [Abstract][Full Text] [Related]
3. [Clinical Characteristics and Therapeutic Efficacy of Multiple Myeloma Combined with Renal Amyloidosis].
Wen HY; Gan SL; Ma J; Xie XS; Liu YF; Jiang ZX; Sun L; Liu LX; Wang F; Meng XL; Chen SQ; Chen YD; Wan DM; Sun H
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2016 Apr; 24(2):474-7. PubMed ID: 27151013
[TBL] [Abstract][Full Text] [Related]
4. [Renal disorders associated with monoclonal gammopathies: diagnostic and therapeutic progress].
Bridoux F; Delbes S; Sirac C; Pourreau F; Puyade M; Desport E; Jaccard A; Fermand JP; Touchard G
Presse Med; 2012 Mar; 41(3 Pt 1):276-89. PubMed ID: 22244725
[TBL] [Abstract][Full Text] [Related]
5. Long-term outcome according to renal histological lesions in 118 patients with monoclonal gammopathies.
Montseny JJ; Kleinknecht D; Meyrier A; Vanhille P; Simon P; Pruna A; Eladari D
Nephrol Dial Transplant; 1998 Jun; 13(6):1438-45. PubMed ID: 9641173
[TBL] [Abstract][Full Text] [Related]
6. The Scope of Kidney Affection in Monoclonal Gammopathies at All Levels of Clinical Significance.
Mehtat Ünlü Ş; Özsan H; Sarıoğlu S
Turk J Haematol; 2017 Dec; 34(4):282-288. PubMed ID: 28832010
[TBL] [Abstract][Full Text] [Related]
7. Unusual morphology of amyloid cast nephropathy in renal biopsy portending poor prognosis.
Rajagopal MD; Nachiappa Ganesh R; Parameswaran S; Puthiyottil D
BMJ Case Rep; 2018 Dec; 11(1):. PubMed ID: 30580293
[TBL] [Abstract][Full Text] [Related]
8. Rapid Deterioration of the Renal Function Caused by the Coexistence of Intratubular Amyloidosis and Myeloma Cast Nephropathy.
Kato H; Fujigaki Y; Asakawa S; Yamaguchi Y; Uozaki H; Komatsuda A; Nagata M; Uchida S
Intern Med; 2015; 54(23):3023-8. PubMed ID: 26631886
[TBL] [Abstract][Full Text] [Related]
9. [Diagnosis and treatment of kidney involvement in plasma cell diseases : Renal involvement in multiple myeloma and monoclonal gammopathies].
Gödecke V; Schmidt JJ; Bräsen JH; Koenecke C; Haller H
Internist (Berl); 2019 Jan; 60(1):10-22. PubMed ID: 30635666
[TBL] [Abstract][Full Text] [Related]
10. Prognostic value of kidney biopsy in myeloma cast nephropathy: a retrospective study of 70 patients.
Ecotière L; Thierry A; Debiais-Delpech C; Chevret S; Javaugue V; Desport E; Belmouaz S; Quellard N; Kaaki S; Goujon JM; Fermand JP; Touchard G; Bridoux F
Nephrol Dial Transplant; 2016 Jan; 31(1):64-72. PubMed ID: 26289418
[TBL] [Abstract][Full Text] [Related]
11. Frequency of light chain deposition nephropathy relative to renal amyloidosis and Bence Jones cast nephropathy in a necropsy study of patients with myeloma.
Iványi B
Arch Pathol Lab Med; 1990 Sep; 114(9):986-7. PubMed ID: 2117910
[TBL] [Abstract][Full Text] [Related]
12. Myeloma cast nephropathy with diffuse amyloid casts without systemic amyloidosis: two cases report.
Yong ZH; Yu XJ; Lin ZS; Zhou FD; Cen XN; Wang SX; Zhao MH
BMC Nephrol; 2021 Jan; 22(1):6. PubMed ID: 33407225
[TBL] [Abstract][Full Text] [Related]
13. [Instructions and implementations for percutaneous renal biopsy. Guidelines for the therapy of glomerular nephropaties].
Cagnoli L;
G Ital Nefrol; 2003; 20 Suppl 24():S3-47. PubMed ID: 14666502
[TBL] [Abstract][Full Text] [Related]
14. [Exploration of early assessment of renal impairment in multiple myeloma].
Zhong Y; Yuan ZG; Fu WJ; Zhou F; Zhang CY; Zhang WH; Hou J
Zhonghua Xue Ye Xue Za Zhi; 2012 Oct; 33(10):819-22. PubMed ID: 23384902
[TBL] [Abstract][Full Text] [Related]
15. Late-stage myeloma invades kidney without significant effect on renal function: findings from 53 autopsies in a single institute.
Takano J; Mine S; Mochizuki M; Tanaka N; Hagiwara S
Int J Hematol; 2019 Feb; 109(2):147-153. PubMed ID: 30327925
[TBL] [Abstract][Full Text] [Related]
16. Combined proximal tubulopathy, crystal-storing histiocytosis, and cast nephropathy in a patient with light chain multiple myeloma.
Wu CK; Yang AH; Lai HC; Lin BS
BMC Nephrol; 2017 May; 18(1):170. PubMed ID: 28545410
[TBL] [Abstract][Full Text] [Related]
17. Screening and differential diagnosis of renal light chain-associated diseases.
Gerth J; Sachse A; Busch M; Illner N; Muegge LO; Gröne HJ; Wolf G
Kidney Blood Press Res; 2012; 35(2):120-8. PubMed ID: 22056791
[TBL] [Abstract][Full Text] [Related]
18. The clinicopathological spectrum of renal amyloidosis.
Hsu JY; Shu KH; Chan LP; Lu YS; Cheng CH; Sheu SS; Lian JD
Zhonghua Yi Xue Za Zhi (Taipei); 1994 Oct; 54(4):230-9. PubMed ID: 7982133
[TBL] [Abstract][Full Text] [Related]
19. Trends in Survival and Renal Recovery in Patients with Multiple Myeloma or Light-Chain Amyloidosis on Chronic Dialysis.
Decourt A; Gondouin B; Delaroziere JC; Brunet P; Sallée M; Burtey S; Dussol B; Ivanov V; Costello R; Couchoud C; Jourde-Chiche N
Clin J Am Soc Nephrol; 2016 Mar; 11(3):431-41. PubMed ID: 26728585
[TBL] [Abstract][Full Text] [Related]
20. [Renal disease in multiple myeloma].
Hiromura K; Nojima Y
Nihon Rinsho; 2007 Dec; 65(12):2229-34. PubMed ID: 18069265
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
